Tilray Brands

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Tilray Brands and other ETFs, options, and stocks.

About TLRY

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. 

CEO
Irwin David Simon
CEOIrwin David Simon
Employees
2,842
Employees2,842
Headquarters
Leamington, Ontario
HeadquartersLeamington, Ontario
Founded
2018
Founded2018
Employees
2,842
Employees2,842

TLRY Key Statistics

Market cap
1.11B
Market cap1.11B
Price-Earnings ratio
-0.42
Price-Earnings ratio-0.42
Dividend yield
Dividend yield
Average volume
33.01M
Average volume33.01M
High today
$10.30
High today$10.30
Low today
$9.51
Low today$9.51
Open price
$10.10
Open price$10.10
Volume
6.59M
Volume6.59M
52 Week high
$23.20
52 Week high$23.20
52 Week low
$3.51
52 Week low$3.51

Stock Snapshot

With a market cap of 1.11B, Tilray Brands(TLRY) trades at $9.51. The stock has a price-to-earnings ratio of -0.42.

On 2025-12-28, Tilray Brands(TLRY) stock moved within a range of $9.51 to $10.30. With shares now at $9.51, the stock is trading +0.0% above its intraday low and -7.7% below the session's peak.

Trading volume for Tilray Brands(TLRY) stock has reached 6.59M, versus its average volume of 33.01M.

The stock's 52-week range extends from a low of $3.51 to a high of $23.20.

The stock's 52-week range extends from a low of $3.51 to a high of $23.20.

TLRY News

Nasdaq 4d
This Stock Has Almost Tripled in 6 Months. Here's What Investors Need to Watch Next

Key Points Tilray's shares have soared since mid-2025, driven by expectations of cannabis reclassification in the U.S. These expectations have now become a re...

This Stock Has Almost Tripled in 6 Months. Here's What Investors Need to Watch Next
Nasdaq 5d
President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys?

Key Points Trump's executive order to reclassify marijuana from Schedule I to Schedule III recognized the valid medical uses of the drug. The move could impac...

President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys?

Analyst ratings

64%

of 11 ratings
Buy
36.4%
Hold
63.6%
Sell
0%

People also own

Based on the portfolios of people who own TLRY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.